Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002032078 | SCV002312088 | uncertain significance | MHC class I deficiency | 2021-10-13 | criteria provided, single submitter | clinical testing | This sequence change affects the initiator methionine of the TAP2 mRNA. The next in-frame methionine is located at codon 138. This variant is present in population databases (rs775391251, ExAC 0.03%). This variant has not been reported in the literature in individuals affected with TAP2-related conditions. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |